# OnCo record radionetics-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/radionetics-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "radionetics-oncology" ;
  schema:name "Radionetics Oncology"@en ;
  schema:description "Radionetics Oncology makes small-molecule drugs that carry a radioactive isotope to receptors on the surface of cancer cells that have rarely been targeted before. Eli Lilly paid 140 million dollars in 2024 for the right to buy the company for 1 billion dollars."@en ;
  schema:url <https://onco.cc/companies/radionetics-oncology/>, <https://radionetics.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://radionetics.com/>, <https://radionetics.com/news/radionetics-oncology-raises-52-5m-series-a>, <https://radionetics.com/news/radionetics-oncology-enters-into-strategic-agreement-with-lilly> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> .